
Surgery Partners Increases Bond Consent Fee to $5.00
Surgery Partners, Inc. announced an increase in the consent fee for its subsidiary's solicitation of consents regarding its 7.250% Senior Notes due 2032. The fee has been raised from $2.50 to $5.00 per $1,000 principal amount for holders who consent before the expiration on November 20, 2026. This solicitation is in connection with the company's previously announced merger agreement with Spyglass Topco, LLC. The proposed amendments to the indenture aim to designate BSMH and its affiliates as "Permitted Holders" post-merger, though these amendments are not a condition for the merger's consummation.
Key Highlights
- Surgery Partners' subsidiary increased the consent fee for its 7.250% Senior Notes due 2032 from $2.50 to $5.00 per $1,000 principal.
- The consent solicitation is related to the company's pending merger with Spyglass Topco, LLC.
- The proposed amendments to the indenture will designate BSMH and its affiliates as 'Permitted Holders' post-merger.
- The consent solicitation expires on November 20, 2026, unless extended.
- Consummation of the merger would constitute a 'Change of Control' under the current indenture.
Price Impact
More from SGRY
Surgery Partners' Noteholders Consent to Indenture Amendments for Merger
Surgery Partners Increases Consent Fee for Senior Notes Solicitation
Surgery Partners Reports Q3 Loss of $21.1M; Sells Hospitals for $796.6M